Hear how past DES lessons and today’s newest tech are shaping Medtronic’s future coronary strategy

In this episode, Jason Fontana, vice president coronary and renal denervation marketing and strategy at Medtronic, will walk us through Medtronic’s successful entry into the drug-eluting stent market over a decade ago with the Endeavor DES, the first modular drug-eluting stent. With a focus on healing and deliverability, Medtronic overcome a late-start to become a leader of the pack following the approval of the Resolute Integrity DES. We’ll review Medtronic’s current coronary portfolio including Onyx Frontier DES with a dual flex balloon. Fontana will also explain how new technologies and diagnostic techniques will help it set the pace in the coronary space in the future. Thanks to Delve for sponsoring! Thank you for listening to the MedtronicTalks Podcast.

You can listen to Hear how past DES lessons and today’s newest tech are shaping Medtronic’s future coronary strategy online on Radio and Podcast. Open the player on this page to stream the available audio.

Hear how past DES lessons and today’s newest tech are shaping Medtronic’s future coronary strategy is an episode from MedtronicTalks by MedtronicTalks.

This episode is 00:36:53 long.

This episode was published on Sep 28, 2022.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from MedtronicTalks when more episodes are available from the podcast feed.